Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q2 2025 to Q3 2025
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 2
- Est. +$5.07M
- Added
- 20
- Est. +$13.3M
- Reduced
- 20
- Est. −$9.21M
- Sold out
- 2
- Est. −$774.6K
Portfolio value went from $89.5M to $103.8M (+$14.3M (+16.0%)); positions from 43 to 43 (0).
All Q3 2025 holdingsAll Q2 2025 holdings
In the shares, value and % of portfolio columns, the top figure is Q3 2025 and the gray one below is Q2 2025. For stocks that split between the two quarters, Q2 2025 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| iShares Tr46435G516 | Added– | 185,23072,693 | +112,537+154.8% | $17.2M$6.49M | +$10.5M | 16.6%7.2% | +9.34 |
| Nushares ETF Tr67092P300 | Reduced– | 247,947345,887 | −97,940−28.3% | $10.9M$14.5M | −$4.29M | 10.5%16.2% | −5.73 |
| iShares MSCI USA Momentum Factor ETF46432F396 | Reduced– | 37,49440,843 | −3,349−8.2% | $9.62M$9.82M | −$858.9K | 9.3%11.0% | −1.70 |
| iShares Inc46434G863 | Added– | 197,985140,414 | +57,571+41.0% | $8.60M$5.50M | +$2.50M | 8.3%6.1% | +2.14 |
| Vanguard Ftse Emerging Markets ETF922042858 | Reduced– | 136,722172,044 | −35,322−20.5% | $7.41M$8.51M | −$1.91M | 7.1%9.5% | −2.37 |
| Vanguard Ftse Developed Markets ETF921943858 | Added– | 110,468110,174 | +294+0.3% | $6.62M$6.28M | +$17.6K | 6.4%7.0% | −0.64 |
| DBX ETF Tr233051200 | Reduced– | 119,658126,874 | −7,216−5.7% | $5.55M$5.55M | −$335.0K | 5.3%6.2% | −0.85 |
| iShares Core High Dividend ETF46429B663 | Reduced– | 39,88941,996 | −2,107−5.0% | $4.88M$4.92M | −$258.0K | 4.7%5.5% | −0.79 |
| Flexshares Tr33939L688 | New– | 24,3700 | +24,370 | $4.81M$0 | +$4.81M | 4.6%0.0% | +4.63 |
| iShares MSCI USA Min Vol Factor ETF46429B697 | Reduced– | 45,15345,174 | −210.0% | $4.30M$4.24M | −$2.00K | 4.1%4.7% | −0.60 |
| Vanguard Morningstar Value ETF922908744 | Added– | 16,44416,391 | +53+0.3% | $3.07M$2.90M | +$9.88K | 3.0%3.2% | −0.28 |
| iShares Core S&P 500 ETF464287200 | Reduced– | 4,0464,419 | −373−8.4% | $2.71M$2.74M | −$249.7K | 2.6%3.1% | −0.46 |
| NVDANVIDIA Corp | ReducedHistory | 13,97514,852 | −877−5.9% | $2.61M$2.35M | −$163.6K | 2.5%2.6% | −0.11 |
| Vanguard Morningstar Small-Cap ETF922908751 | Added– | 9,5349,503 | +31+0.3% | $2.42M$2.25M | +$7.88K | 2.3%2.5% | −0.18 |
| SPYSPDR S&P 500 ETF Trust | AddedHistory | 2,7522,746 | +6+0.2% | $1.83M$1.70M | +$4.00K | 1.8%1.9% | −0.13 |
| iShares Inc46434G509 | Reduced– | 48,45564,057 | −15,602−24.4% | $1.63M$1.93M | −$525.0K | 1.6%2.2% | −0.58 |
| JPMJPMorgan Chase & Co | AddedHistory | 3,3373,321 | +16+0.5% | $1.05M$963.0K | +$5.05K | 1.0%1.1% | −0.06 |
| WisdomTree Tr97717W562 | Reduced– | 17,91920,571 | −2,652−12.9% | $1.00M$1.05M | −$148.2K | 1.0%1.2% | −0.21 |
| First Tr Exchange-Traded FD33738D101 | Reduced– | 18,95418,970 | −16−0.1% | $726.0K$712.0K | −$612.85 | 0.7%0.8% | −0.10 |
| Vanguard World FD921910709 | Added– | 9,5049,389 | +115+1.2% | $651.0K$632.0K | +$7.88K | 0.6%0.7% | −0.08 |
| iShares Tr464288661 | Reduced– | 4,9045,119 | −215−4.2% | $586.0K$610.0K | −$25.7K | 0.6%0.7% | −0.12 |
| DEDeere & Co | AddedHistory | 1,1291,126 | +3+0.3% | $516.0K$572.0K | +$1.37K | 0.5%0.6% | −0.14 |
| ProShares Tr74347R107 | Added– | 4,0664,050 | +16+0.4% | $455.9K$395.8K | +$1.79K | 0.4%0.4% | 0.00 |
| ABTAbbott Laboratories | AddedHistory | 3,0122,893 | +119+4.1% | $403.5K$393.5K | +$15.9K | 0.4%0.4% | −0.05 |
| MDTMedtronic plc | ReducedHistory | 4,1454,333 | −188−4.3% | $394.7K$377.7K | −$17.9K | 0.4%0.4% | −0.04 |
| UNHUnitedHealth Group Inc | AddedHistory | 1,130734 | +396+54.0% | $390.0K$229.0K | +$136.7K | 0.4%0.3% | +0.12 |
| ProShares Tr74347R842 | Added– | 7,9457,907 | +38+0.5% | $368.3K$297.9K | +$1.76K | 0.4%0.3% | +0.02 |
| EWEdwards Lifesciences Corp | AddedHistory | 4,4924,445 | +47+1.1% | $349.3K$347.6K | +$3.66K | 0.3%0.4% | −0.05 |
| PFEPfizer Inc | ReducedHistory | 12,57813,428 | −850−6.3% | $320.5K$325.5K | −$21.7K | 0.3%0.4% | −0.05 |
| INCYIncyte Corp | ReducedHistory | 3,7445,094 | −1,350−26.5% | $317.5K$346.9K | −$114.5K | 0.3%0.4% | −0.08 |
| iShares Tr464288513 | Added– | 3,2293,183 | +46+1.4% | $262.0K$257.0K | +$3.73K | 0.3%0.3% | −0.03 |
| DHRDanaher Corp | NewHistory | 1,3130 | +1,313 | $260.3K$0 | +$260.3K | 0.3%0.0% | +0.25 |
| iShares Tips Bond ETF464287176 | Reduced– | 2,2112,452 | −241−9.8% | $246.0K$270.0K | −$26.8K | 0.2%0.3% | −0.06 |
| iShares Tr464288372 | Unchanged– | 3,9053,905 | 00.0% | $239.0K$231.0K | $0 | 0.2%0.3% | −0.03 |
| REGNRegeneron Pharmaceuticals, Inc. | ReducedHistory | 412490 | −78−15.9% | $231.8K$257.1K | −$43.9K | 0.2%0.3% | −0.06 |
| PMPhilip Morris International Inc. | AddedHistory | 1,4241,413 | +11+0.8% | $231.0K$257.0K | +$1.78K | 0.2%0.3% | −0.06 |
| iShares Iboxx $ Investment Grade Corporate Bond ETF464287242 | Added– | 1,9911,975 | +16+0.8% | $222.0K$216.0K | +$1.78K | 0.2%0.2% | −0.03 |
| ZURAZura Bio Ltd | ReducedHistory | 21,51863,985 | −42,467−66.4% | $93.2K$67.2K | −$183.9K | 0.1%0.1% | +0.01 |
| ANNXAnnexon, Inc. | ReducedHistory | 27,02727,575 | −548−2.0% | $82.4K$66.2K | −$1.67K | 0.1%0.1% | +0.01 |
| NKTXNkarta, Inc. | AddedHistory | 39,45227,979 | +11,473+41.0% | $81.7K$46.4K | +$23.7K | 0.1%0.1% | +0.03 |
| GERNGeron Corp | AddedHistory | 52,25835,181 | +17,077+48.5% | $71.6K$49.6K | +$23.4K | 0.1%0.1% | +0.01 |
| MREOMereo BioPharma Group plc | AddedHistory | 33,18019,138 | +14,042+73.4% | $68.4K$51.9K | +$28.9K | 0.1%0.1% | +0.01 |
| CTMXCytomX Therapeutics, Inc. | ReducedHistory | 18,10927,698 | −9,589−34.6% | $57.8K$62.9K | −$30.6K | 0.1%0.1% | −0.01 |
| iShares MSCI India ETF46429B598 | Sold out– | 07,426 | −7,426−100.0% | $0$413.5K | −$413.5K | 0.0%0.5% | −0.46 |
| TMOThermo Fisher Scientific Inc. | Sold outHistory | 0891 | −891−100.0% | $0$361.1K | −$361.1K | 0.0%0.4% | −0.40 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.